2012 Hemostasis Gordon Research Conference and Gordon Research Seminar

2012止血戈登研究会议暨戈登研究研讨会

• 批准号: 8388646
• 负责人: Sriram Krishnaswamy
• 金额: $ 1.95万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-07-15 至 2013-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8388646
• 关键词: Achievement; Affect; Animal Model; Applied Research; Area; Basic Science; Biochemistry; Biology; Biotechnology; Blood Clot; Blood Platelets; Blood Vessels; Blood coagulation; Cardiovascular Diseases; Cessation of life; Clinical Research; Coagulation Process; Commit; Communities; Development; Diagnosis; Discipline; Disease; Ensure; Environment; Enzymatic Biochemistry; Equilibrium; Faculty; Fostering; Future; Genetic; Goals; Health; Hemorrhage; Hemostatic Agents; Hemostatic function; Human; Individual; Infection; Inflammation; International; Medical; Medicine; Membrane; Minority; Molecular Biology; Nature; Pharmacologic Substance; Physicians; Play; Postdoctoral Fellow; Process; Proteins; Receptor Signaling; Regulation; Research; Research Personnel; Role; Scientist; Series; Site; Students; Talents; Thrombosis; Thrombus; Training; Transgenic Animals; Travel; Woman; Work; abstracting; atherothrombosis; catalyst; cost; disability; experience; human disease; improved; innovation; interest; man; meetings; programs; social; structural biology; success; symposium; tool

DESCRIPTION (provided by applicant): We request partial support for a Gordon Research Conference and Gordon Research Seminar on Hemostasis. The proposed conference is to be held at the GRC site in Waterville Valley, NH, July 22-27, 2012. This conference in 2012 is the 31st such meeting since its inception in 1973 that is now being held biennially. The meeting in 2010 was approved to be held in conjunction with a 1 day Gordon Research Seminar dedicated to trainee presentations and to enhance their profile at the GRC. We are delighted to be again approved to hold the 1 day Gordon Research Seminar to precede the Hemostasis GRC in 2012. The Hemostasis Gordon Research Conference brings together scientists interested in the biology, biochemistry and genetics of platelets and coagulation proteins, physicians involved in the treatment of bleeding and thrombotic diseases and investigators from small and large pharmaceutical companies developing new therapies for hemostatic disorders. The conference has legendary status establishing it as the forum at which cutting-edge research is presented and major advances in the field are unveiled. Indeed, some of the most spectacular recent achievements in hemostasis have been first unveiled at previous conferences in this series or have been driven by collaborative interactions fostered by this conference. The roster of invited speakers and discussion leaders who have already agreed to participate is impressive and represents top investigators in the field. These attendees will enhance the stimulating nature of the environment for all attendees and especially junior investigators and trainees. Trainee participation in the meeting will be greatly enhanced by the popular Gordon Research Seminar. As in past conferences, we will endeavor to promote participation by women and minorities and facilitate attendance by junior faculty, students, postdoctoral fellows and individuals with physical disabilities. The program currently includes a Historical Perspective Session to begin the meeting on a lighter/general interest note and 8 sessions: 1. Inflammation/Infection and Coagulation; 2. Thrombus Formation and its Dissolution; 3. Defective Hemostasis; 4. Blood/Vessel Wall Interface; 5. Receptors and Signaling; 6. Hot Topic Abstract Talks; 7. Regulation of Thrombus Formation; 8. Membranes/Microparticles/ Atherothrombosis. PUBLIC HEALTH RELEVANCE: We request partial support for a Gordon Research Conference focused on normal blood coagulation as well as excessive bleeding and thrombosis prevalent in human disease. This is a cutting edge conference that brings together outstanding scientists doing research in the diverse facets that affect blood clotting. The meeting enjoys an international reputation for being the forum at which new advances in the field are unveiled.

描述（由申请人提供）：我们要求对戈登研究会议和戈登止血研究研讨会进行部分支持。拟议的会议将于2012年7月22日至27日在新罕布什尔州沃特维尔谷的GRC遗址举行。2012年的这次会议是自1973年成立以来的第31届此类会议，该会议现已两年来举行。 2010年的会议被批准与致力于学员演讲的为期1天的戈登研究研讨会一起举行，并在GRC上提高了他们的概况。我们很高兴再次获得批准，以在2012年举行的为期1天的戈登研究研讨会，以在2012年止血性GRC之前。止血性戈登研究会议汇集了对生物学，生物化学和遗传学感兴趣的科学家以及凝结蛋白的生物化学和遗传学，并涉及促进肿瘤和肿瘤疾病的医师，并涉及小型疾病和肿瘤疾病的医师。疾病。该会议具有传奇地位，将其确立为介绍尖端研究的论坛，并揭幕了该领域的重大进展。的确，在本系列的先前会议上首先在止血性中最杰出的成就，或者是由本次会议促进的合作互动所驱动的。已经同意参加的邀请演讲者和讨论领袖的名册令人印象深刻，代表了该领域的顶级调查员。这些与会者将增强所有与会者，尤其是初级调查人员和受训者的刺激性性质。受欢迎的戈登研究研讨会将大大提高受训者参加会议。与过去的会议一样，我们将努力促进妇女和少数民族的参与，并促进初中教职员工，学生，博士后研究员和身体残障人士的出席。该计划当前包括一个历史观点会议，以开始会议，以更轻/一般的兴趣注释和8次会议：1。炎症/感染和凝结； 2。血栓形成及其溶解； 3。止血有缺陷； 4。血/容器壁界面； 5。受体和信号传导； 6。热门话题抽象谈话； 7。血栓形成的调节； 8。膜/微粒/动脉粥样硬化。公共卫生相关性：我们要求对戈登研究会议进行部分支持，该会议的重点是正常血液凝血以及人类疾病中普遍存在的出血和血栓形成。这是一次尖端会议，将杰出的科学家汇集在一起​​，以影响血液凝结的各个方面进行研究。这次会议享有国际声誉，因为它是该领域新进步的论坛。